Pfizer RxPathways Patient Assistance Program:
ENROLLMENT FORM FOR GROUP B MEDICINES
Do I Qualify For Free Medicine Through Pfizer RxPathways?
You are eligible for free medicine and should complete this enrollment form if you:
Have been prescribed a Pzer Group B medicine listed on page 2
Live in the United States, Puerto Rico, or the US Virgin Islands
Have no prescription coverage, or not enough coverage to pay for your Pfizer medicine
Meet certain income limits, which vary by product and household size
How Can I Apply?
For immediate assistance with access to specialty or oncology medicines, please call Pfizer RxPathways
at 877-744-5675, M-F, during the hours of 8 AM-8 PM ET.
1. Fill out and sign the patient section of this enrollment form.
2. Ask your prescriber to fill out and sign the prescriber section and complete the prescription/order section
of this enrollment form.
3. Gather the following required documents:
Completed and signed enrollment form (both Patient and Prescriber sides)
A photocopy of one of the following documents that shows your total annual income: Previous years federal
tax return (form 1040 or 1040EZ); Two recent paycheck stubs; Wage and tax statements (W-2 forms);
Social security, pension, or railroad retirement statements (SSA-1099 or similar); Statements of interest,
dividends, or other income (1099-INT, 1099, 1099-DIV, or similar forms)
4. Make a photocopy of your enrollment form and income documentation, as they typically will not be returned
to you.
5. Mail all required documents or have your Prescriber fax to the number below:
Pfizer RxPathways
P.O. Box 66976
St. Louis, MO 63166-6976
Fax: 800-708-3430
Tel: 877-744-5675 (M-F, 8 AM-8 PM ET)
Pzer reserves the right to change or cancel the Pfizer RxPathways program at any time.
Pfizer RxPathways, formerly known as Pzer Helpful Answers
®
, is Pzer’s prescription assistance program that pro-
vides eligible patients with access to their Pzer medicines.
This enrollment form is intended for patients who would like to apply to receive any of the medicines listed under
Group B on page 2 for free, or to receive help understanding and using their insurance benefits.
If the Pzer medicines you need help with are not in Group B, or you don’t think you qualify for free medicine and
would like to enroll to receive our savings card,* please call 877-744-5675 (M-F, 8 AM-8 PM ET).
*Terms and conditions apply.
PHA640707-01 © 2014 Pzer Inc. Printed in USA/April 2014 FRMRXP101
Pfizer RxPathways P.O. BOX 66976, ST. LOUIS, MO 63166-6976 T: 877-744-5675 F: 800-708-3430 PfizerRxPath.com
Group B [1]
Pfizer RxPathways
MEDICINE LIST
PHA640707-01 © 2014 Pzer Inc. Printed in USA/April 2014 FRMRXP101
Pfizer RxPathways P.O. BOX 66976, ST. LOUIS, MO 63166-6976 T: 877-744-5675 F: 800-708-3430 PfizerRxPath.com
Group B [2]
Medicines typically prescribed by a Primary Care Physician
GROUP A
Accuretic
(quinapril HCl/hydrochlorothiazide)
Arthrotec
®
(diclofenac sodium/misoprostol) tablets
Caduet
®
(amlodipine besylate/atorvastatin calcium)
Caverject
®
(alprostadil for injection)
Celebrex
®
(celecoxib capsules)
Celontin
®
(methsuximide capsules, USP)
Chantix
®
(varenicline) tablets
Cleocin T
®
(clindamycin phosphate)
Cleocin HCI
®
(clindamycin hydrochloride, USP)
Cleocin Pediatric
®
(clindamycin palmitate hydrochloride
for oral solution, USP)
Cleocin Phosphate
®
(clindamycin phosphate, USP)
Cleocin
®
(clindamycin phosphate, USP)
Colestid
®
(colestipol hydrochloride)
Colestid
®
Flavored (colestipol hydrochloride)
Cortef
®
(hydrocortisone tablets, USP)
Depo
®
-Estradiol (estradiol cypionate injection, USP)
Depo-Medrol
®
(methylprednisolone acetate injectable
suspension, USP)
Depo-Provera
®
(medroxyprogesterone acetate
injectable suspension)
Depo-subQ Provera 104
®
(medroxyprogesterone acetate
injectable suspension 104 mg/0.65 mL)
Detrol
®
LA (tolterodine tartrate extended release capsules)
Detrol
®
(tolterodine tartrate tablets)
Dilantin
®
(extended phenytoin sodium capsules, USP)
Dilantin
®
(phenytoin, USP) Infatabs
®
Dilantin-125
®
(phenytoin oral suspension, USP)
Duavee
(conjugated estrogens/bazedoxifene)
Effexor XR
®
(venlafaxine hydrochloride)
extended-release capsules
Estring
®
(estradiol vaginal ring)
Feldene
®
(piroxicam)
Glyset
®
(miglitol tablets)
Inspra
(eplerenone)
Levoxyl
®
(levothyroxine sodium tablets)
Lincocin
®
(lincomycin injection, USP)
Lyrica
®
(pregabalin) capsules
Mycobutin
®
(rifabutin capsules, USP)
Nardil
®
(phenelzine sulfate tablets, USP)
Nicotrol
®
(nicotine)
Nitrostat
®
(nitroglycerin, USP)
Norpace
®
(disopyramide phosphate capsules)
Norpace
®
CR (disopyramide phosphate
extended-release capsules)
Premarin
®
(conjugated estrogens tablets, USP)
Premarin
®
(conjugated estrogens) Vaginal Cream
Premphase
®
(conjugated estrogens plus
medroxyprogesterone acetate tablets)
Prempro
®
(conjugated estrogens/
medroxyprogesterone acetate tablets)
Pristiq
®
(desvenlafaxine) extended-release tablets
Procardia XL
®
(nifedipine) extended release tablets
Procardia
®
(nifedipine) capsules
Protonix
®
(pantoprazole sodium)
Provera
®
(medroxyprogesterone acetate tablets, USP)
Quillivant
XR (methylphenidate hydrochloride) for
extended-release oral suspension
Relpax
®
(eletriptan HBr)
Skelaxin
®
(metaxalone)
Synarel
®
(nafarelin acetate) nasal solution
Tessalon
®
(benzonatate)
Tikosyn
®
(dofetilide)
Toviaz
®
(fesoterodine fumarate extended release tablets)
Trecator
®
(ethionamide tablets)
Viagra
®
(sildenafil citrate) tablets
Xalatan
®
(latanoprost ophthalmic solution)
Zarontin
®
(ethosuximide capsules, USP)
Medicines typically prescribed by a Specialist
GROUP B
Aromasin
®
(exemestane tablets)
BeneFIX
®
(coagulation factor IX (recombinant))
Bosulif
®
(bosutinib)
Camptosar
®
(irinotecan HCl injection)
Ellence
®
(epirubicin hydrochloride injection)
Emcyt
®
(estramustine phosphate sodium capsules)
Idamycin PFS
®
(idarubicin hydrochloride for
injection, USP)
Inlyta
®
(axitinib) tablets
Neumega
®
(oprelvekin)
Rapamune
®
(sirolimus)
Revatio
®
(sildenal) tablets
Sutent
®
(sunitinib malate)
Torisel
®
(temsirolimus) injection
Tygacil
®
(tigecycline) for injection
Vfend
®
(voriconazole)
Xalkori
®
(crizotinib)
Xyntha
®
(antihemophilic factor (recombinant),
plasma/albumin-free)
Zinecard
®
(dexrazoxane for injection)
GROUP C
Prevnar 13
®
(Pneumococcal 13-valent Conjugate
Vaccine [Diphtheria CRM
197
Protein])
Vaccines
Enrollment Form for Group B Medicines:
PATIENT SECTION
PATIENT INFORMATION (All fields are required):
Patient Name: Gender: Male Female
Patient Address:
City: State: Zip Code:
E-Mail:
Telephone: Date of Birth: (MM/DD/YY):
Total Number of People Within Household (including applicant):
Total Annual Income for Entire Household:
Please submit documentation to support the financial information you’ve listed. Attached is:
Most recent federal tax return W-2 form Other
Do you have prescription coverage? Yes (If Yes, please complete section 2) No
1
( )
/ /
PATIENT PRIVACY AND CONSENT (Read and signature required below):
The information you provide will be used by Pzer, the Pzer Patient Assistance Foundation and parties acting on their behalf to determine
eligibility, to manage and improve the Pzer RxPathways program, products and services, to communicate with you about your experience
with the Pzer RxPathways program, and/or to send you materials and other helpful information and updates relating to Pzer programs.
By signing below, I afrm that my answers and my proof-of-income documents are complete, true and accurate to the best of my knowledge.
I understand that:
Completing this enrollment form does not guarantee that I will qualify for Pfizer RxPathways.
Pzer may verify the accuracy of the information I have provided and may ask for more financial and insurance information.
Any medicines supplied by the Pzer RxPathways program shall not be sold, traded, bartered or transferred.
Pzer reserves the right to change or cancel the Pfizer RxPathways program, or terminate my enrollment, at any time.
The support provided in this program is not contingent on any future purchase.
I certify and attest that if I receive medicine(s) provided by Pzer through the Pfizer RxPathways program:
I will promptly contact Pfizer RxPathways if my financial status or insurance coverage changes.
• I will not seek to have this medicine or any cost from it counted in my Medicare Part D out-of-pocket expenses for prescription drugs.
I will not seek reimbursement or credit for the medicine(s) from my prescription insurance provider or payor, including
Medicare Part D plans for any costs of medications.
I will notify my insurance provider of the receipt of any medicines through Pfizer RxPathways.
I have a signed copy of a current and completed HIPAA Authorization Form on record with my Prescriber so that my Prescriber may
share health information about me with the Pfizer RxPathways program, Pzer Inc., and the Pfizer Patient Assistance Foundation Inc.
Signature of Patient
(Parent or guardian, if under 18 years of age) X Date:
PRESCRIPTION COVERAGE AND INSURANCE INFORMATION (All fields are required):
Is the Pfizer Medicine you have been prescribed covered on your prescription plan? Yes No
Please check the one box that best describes your prescription coverage type:
Medicare Part-D Medicaid Private/Employer State Healthcare Exchange Other
Primary Insurance Co. Name: Phone #:
Policy Holder Name: Policy Holder DOB:
Policy Holder SSN: Policy #: Group #:
Prescription Card Name: Phone #:
RxBin #: PCN# Policy #: Group #:
Secondary Insurance Co. Name: Phone #:
Policy Holder Name: Policy Holder DOB:
Policy Holder SSN: Policy #: Group #:
Prescription Card Name: Phone #:
RxBin #: PCN# Policy #: Group #:
4
2
– –
( )
( )
/ /
( )
– –
/ /
SUTENT IN Touch, a free support program for patients starting treatment (For Sutent patients only):
By checking this box, I agree that the information I provide will be used by Pzer and parties acting on its behalf to send me the materials
I requested and other helpful information and updates on SUTENT and/or my condition as well as related treatments, products, offers and
services, including information about the Sutent In Touch Call Center. Pfizer may also use my information to communicate with me and
my health care provider in relation to my treatment.
3
PHA640707-01 © 2014 Pzer Inc. Printed in USA/April 2014 FRMRXP101
Pfizer RxPathways P.O. BOX 66976, ST. LOUIS, MO 63166-6976 T: 877-744-5675 F: 800-708-3430 PfizerRxPath.com
Group B [3]
( )
Enrollment Form for Group B Medicines:
PRESCRIBER SECTION
PHA640707-01 © 2014 Pzer Inc. Printed in USA/April 2014 FRMRXP101
Pfizer RxPathways P.O. BOX 66976, ST. LOUIS, MO 63166-6976 T: 877-744-5675 F: 800-708-3430 PfizerRxPath.com
PRESCRIBER INFORMATION (To be completed by the provider)
Prescriber Name & Title: NPI #:
Payer Specific #: Tax ID #:
State License #: DEA #:
Office Contact Name:
Name of Facility:
Facility Address:
City: State: Zip Code:
Phone: Fax:
Ship to: Prescriber Patient
Prescriber E-mail Address:
Please provide diagnosis and specific ICD-9 code:
( ) ( )
1
Group B [4]
PRESCRIBER PRIVACY AND CONSENT (Read and sign below):
The information you provide will be used by Pzer to improve and tailor our products and services to better serve you. The information
will also be used by the Pzer Patient Assistance Foundation and parties acting on their behalf to administer and improve Pzer
RxPathways programs, products, and services, to communicate with you about your experience with Pzer RxPathways, and/or to send
you materials and other helpful information and updates relating to Pfizer RxPathways.
By signing below, you, the Prescriber, understand and agree to the following:
• I certify that the information provided is current, complete, and accurate to the best of my knowledge.
• I understand that completing this enrollment form does not guarantee that assistance will be provided to my patient.
• I will receive and secure my patient’s medication at my office until its dispensed to my patient, when applicable.
• I will comply with and abide by your State Practitioner Dispensing Laws for authorized Prescribers, when applicable.
• Any medications supplied by Pzer as a result of this enrollment form are for the use of the patient named on this form only, and
shall not be sold, traded, bartered, transferred, returned for credit, or submitted to any third party (such as Medicare, Medicaid or
other benefit provider) for reimbursement.
• The medicine will be provided only to this eligible and enrolled patient at no charge of any kind.
• Pzer may contact the patient directly to conrm receipt of medications.
• The information provided on this enrollment form is subject to random audits and verication.
Pzer may change or cancel this program at any time; Pzer also reserves the right to terminate my patients enrollment at any time.
• I will notify Pfizer RxPathways immediately if the Pzer product is no longer medically necessary for this patient’s treatment
or if my patients insurance or financial status changes.
• I have a signed copy on file of my patient’s current and completed HIPAA Authorization Form so that I may share patient
health information with the Pfizer RxPathways program, Pfizer Inc., and the Pzer Patient Assistance Foundation Inc.
Signature of Prescriber X Date:
2
Torisel
®
(temsirolimus) injection Idamycin
®
(idarubicin hydrochloride) injection
Camptosar
®
(irinotecan hydrochloride) injection Neumega
®
(oprelvekin) injection
Ellence
®
(epirubicin hydrochloride) injection Zinecard
®
(dexrazoxane) injection
Enrollment Form for Group B Medicines:
PRESCRIPTION / ORDER SECTION
PHA640707-01 © 2014 Pzer Inc. Printed in USA/April 2014 FRMRXP101
Pfizer RxPathways P.O. BOX 66976, ST. LOUIS, MO 63166-6976 T: 877-744-5675 F: 800-708-3430 PfizerRxPath.com
Xyntha Antihemophilic Factor, Plasma/Albumin-Free BeneFIX Coagulation Factor IX
250 IU 500 IU 1,000 IU 2,000 IU Monthly dosage: IU
PATIENT INFORMATION
First Name: Last Name:
Date of Birth: Phone #:
Patient Address:
City: State: Zip Code:
Shipping Address (If different than above):
City: State: Zip Code:
PRESCRIPTION (For full prescribing information, go to www.pfizer.com)
Directions: Quantity: Refill: times
Drug Allergies: Yes No If yes, please specify:
Patient’s Concurrent Medications:
Prescribing Physician:
Prescriber Signature: X Date:
Dispense as Written May Substitute
Special Note: New York Prescribers please submit prescription on an original NY State prescription blank, for all other States,
if not faxed, must be on State specific blank if applicable for your State. The prescription is only valid if received by fax meeting
IN and TN regulations.
Please fax completed prescription form to Pzer RxPathways at (800) 708-3430. Prescription valid for one year. Thank You.
Xalkori: 250 mg, 30-day supply
Xalkori: 200 mg, day supply
Sutent: mg, 28-day supply
Sutent: mg, 42-day supply
/ / ( )
Bosulif: mg, 30 day supply
Emcyt: mg, 90 day supply
Aromasin: 25 mg, 90 day supply Inlyta: mg BID, 30 day supply
Vfend: 50 mg, 60 day supply
Vfend: 200 mg, 60 day supply
Revatio: 20 mg, 90 day supply
Rapamune: .5 mg, 90 day supply
Rapamune: 1 mg, 90 day supply
Elelyso: Total dose units every weeks, 28 day supply
Rapamune: 2 mg, 90 day supply
Rapamune Oral Solution: 1 mg
TREATMENT INFORMATION (Indicate amount of Pfizer product requested for patient assistance)
Patient Name:
Treatment Start Date: Dosage:
Dosing Regimen:
Vial Size/# of Vials:
/ /
PHYSICIAN ADMINISTERED PRODUCTS (For IV Oncology Products Only, Complete this Section)
Please check the appropriate Pfizer product (For full prescribing information, go to www.pfizeroncology.com)
3
TRANSPLANT HISTORY (For Rapamune Only, Complete Transplant History)
Transplant Type: Date of Transplant:
Transplant Facility: Medicare Approved Facility: Yes No
4
5
Group B [5]
Save File Print File
Pzer Inc. and the Pzer Patient Assistance Foundation, Inc.
Patient Assistance Programs
HIPAA Authorization Form for the Disclosure of Patient Information
To Pat ient:
The attached authorization is for you and your doctor. If you sign this authorization, you are
allowing your doctor to give Pzer health information about you that will help you get your
Pzer medications. An example of the type of information we need from your doctor would
be the prescription for the medicine you need. This authorization is between you and your
doctor only. Please sign and give your doctor the original signed authorization and keep
a copy for your records. This form should not be returned with your enrollment form.
To Physician:
The attached authorization, when signed by your patient, documents the patient’s permission
for you to share certain medical and personal information with Pzer in connection with
Pzer’s patient assistance programs. This authorization is strictly for your records and
should not be returned with your patient’s enrollment form.
To Patient and Physician, please note:
Pzer Helpful Answers
®
is a joint program of Pzer Inc. and the Pzer Patient Assistance
Foundation™, Inc.
PHA00424AC
HIPAALTR
HIPAA Authorization Form for the Disclosure of Patient Information
FOR PFIZER INC. AND THE PFIZER PATIENT ASSISTANCE FOUNDATION, INC.
PATIENT ASSISTANCE PROGRAMS
To the Patient: Pzer Inc. and the Pzer Patient Assistance Foundation, Inc. offers patient assistance
programs (the “Program”) to help patients who qualify obtain certain Pzer medicines at no cost. In order
to determine your eligibility for the Program and to administer your participation in the Program if you are
accepted, Pzer, along with its afliated companies and contractors who administer the Program, need to obtain
certain information about you from your doctor. Please complete this Authorization, sign and date it, and
return it to your doctor.
To the Physician: Please retain the original signed Authorization with the patients records and
provide a copy to the patient. You do not need to return this patient Authorization to Pzer.
* * *
I request and authorize my doctor, (“Doctor”), to give Pzer
Inc., including representatives and contractors who work on behalf of Pzer in this Program, information
about me and my medical condition, which is necessary to determine my eligibility for the Program and
for my continuing participation in the Program if I am accepted, to administer the Program, to account for
my withdrawal if I decide to stop participating in this Program, and to evaluate patient satisfaction and the
Programs overall effectiveness. The type of information that can be given under this authorization may
include:
My name and birth date
My address and telephone number
My social security number
Financial information about me
Information about my health benets or health insurance coverage
Information on my medical condition, as necessary
I know that I can cancel this authorization at any time by writing to my Doctor at
. If I cancel this
authorization, then my Doctor will stop providing Pzer, and its representatives, with information about me.
However, I cannot cancel actions that have already been taken by relying on my authorization.
I understand that once my Doctor gives Pzer information about me based on this authorization, federal
privacy laws may not prevent Pzer from further disclosing my information. I also understand that signing this
authorization does not guarantee that I will be accepted into a Pzer patient assistance program.
This authorization will expire one (1) year after the date it is signed, below, or one (1) year after the last date
I receive medicines under the Program, whichever is later.
Patient or Personal Representative of Patient {Authority to sign on behalf of Patient (if applicable)}
Signature
Date
Name (please print)
Please return the signed form to your Doctor. You are entitled to a copy for your records.